TruthArchive.ai - Related Video Feed

The speaker discusses mRNA technology and its anticipated role in vaccines, noting that many corporations have banked in the biotech industry with mRNA as the presumed future vaccine technology. They reference a recent Korean cohort study that reportedly found five or six cancers associated with the vaccine, highlighting that this study had large statistical power and evaluated all cancer types. In contrast, they mention that studies examining a single cancer type, such as lymphoma in Sweden, did not find an association. The speaker says the Korean study’s broad analysis is leading to “writings on the wall for mRNA technology,” and asserts they do not believe it will be the future vaccine technology. They shift to a broader threat landscape, arguing that the traditional focus on emerging infectious diseases is outdated. They claim the real threat is not old-world diseases but synthetic pathogens and synthetic life, noting that gain-of-function technology has evolved rapidly in the last two to three years. The speaker states that “the future threat we need to be mitigating against and protecting against is actually synthetic pathogens and synthetic life.” Finally, they assert a provocative claim about life creation, saying, “we've actually already created single cell life. It exists.”

Today's livestream discussed the dangers of nanotechnology in COVID vaccines, revealing that the technology can replicate itself, create neural networks, and build its own AI within the body. The speaker emphasized the urgency of informing the public about this issue and the potential consequences of allowing the technology to continue unchecked. The speaker expressed frustration with the lack of action taken to address the situation and called for immediate action to prevent further harm.

Speaker says, "it's a festering wound for people" and, "we cannot sweep it under the rug." They urge action, noting, "the new administration to step up and do something" because "the next you know, they have 500 mRNA shots in the pipeline." They warn, "33 of those are self amplifying, which is just really terrifying." They ask, "What does that mean? Meaning, like, they're designed to continue to replicate indefinitely." They add, "I mean, already the ones we have, we don't have an off switch, and this is like no off switch on steroids." They claim, "They have them in Japan and India and The EU already." They conclude, "They're the one that I think is in the pipeline in The US is for the h one n one."

A 30,000-person rally in Tokyo protested the deployment of self-replicating RNA vaccines, which some Japanese citizens are calling the "3rd atomic bomb." This deployment is a cooperative agreement between a US company (Arturis), an Australian company (CSL), and a Japanese company. The CEO of the Japanese company stated that anyone spreading misinformation about the vaccine will be pursued legally and potentially jailed. Concerns exist about the untested technology, including its potential to infect others, spread, replicate uncontrollably, and affect the brains of the elderly. The speaker believes this is an attempt to control the narrative, deploy psychological warfare, and suppress dissent, and urges listeners to fight this "new tyranny."

The symposium covers the potential safety and threat of “replicating” vaccines, especially LepriCon (leprecon) vaccines, in the context of Covid-19 vaccines and genome‑editing concepts. The speakers present a chain of claims and concerns, some drawing on reports and others presenting theories about how these next‑generation vaccines could behave in humans and populations. Key points and claims presented - Emerging mechanisms and risks: The panel notes that blood vessel inflammation and thrombosis mechanisms are increasingly observed, including in vaccine contexts, with examples from individuals who needed limb amputation and others who developed severe vascular events after vaccination. One case involved a 70‑year‑old man who, after a third dose, developed embolic events necessitating shoulder joint surgery, and another where a 60‑year‑old man developed acute limb ischemia and died; both are presented as suggesting a serious vascular mechanism linked to vaccination, though causal connections are not established. - Replicating/vector vaccines and their concerns:荒川博士 and others discuss LepiCon vaccines as vaccines that replicate inside the body. The concept involves “replicating viral vectors” where the genome can mutate and evolve during replication. The green‑highlighted segment in a slide (the antigen gene) plus a blue/orange segment (replicating gene cassette) is used to describe how LepriCon vaccines are designed to carry viral genes and replicate, with the assertion that replication, mutation, and recombination can occur, potentially generating new variants inside the host. - Differences from conventional vaccines: The discussion contrasts LepriCon vaccines with standard mRNA vaccines. In conventional mRNA vaccines, messenger RNA is delivered and translated into antigen proteins, then degraded; in LepriCon vaccines, replicating RNA/DNA can persist and continue producing antigen, with mutation and recombination possible. The panel emphasizes that LepriCon vaccines use replicating/copying mechanisms and that the genetic material can be copied in ways that differ from natural human biology, potentially creating unpredictable variants. - Central dogma and exceptions: The speakers reference the central dogma (DNA → RNA → protein) but note exceptions in viruses, including RNA viruses that can reverse‑transcribe to DNA (retroviruses) and RNA viruses that replicate RNA directly. They discuss how LepriCon vaccines would rely on replicative processes that do not follow the usual linear flow and why this could complicate predictions about safety and behavior in humans. - Potential for unintended spread and environmental impact: A major concern raised is that self‑replicating vectors could spread beyond the vaccinated individual, via exosomes or other intercellular transport, creating secondary infections or non‑target spread. Exosomes could ferry replicating genetic material, raising fears of new infection chains or “outbreaks” stemming from the vaccine itself, and even suggesting the possibility of vaccination‑induced spread akin to an attenuated or modified pathogen. - Safety signals and immunology concerns: The discussion touches on immune system risks, including immune dysregulation, autoimmune phenomena, and unexpected inflammatory responses. IGG4‑related disease is highlighted as a potential adverse outcome post‑vaccination, with descriptions of glandular and systemic involvement and the idea that high IGG4 levels could have immunosuppressive effects that alter responses to infection or vaccination. The panel notes observed increases in certain immunoglobulin subclasses after multiple LepriCon doses and discusses the possibility of immune tolerance or enhanced immune responses that could be harmful. - Historical and theoretical context: References are made to past epidemics and speculative pandemics caused by misused or dangerous vaccine platforms, drawing on central molecular biology concepts and historical anecdotes about how vaccines can be designed and misused. The discussion frames LepriCon vaccines as a high‑risk platform that could, in theory, generate recombinants, escape mutations, or cause unintended immune and inflammatory consequences. - Clinical and regulatory implications: The speakers call for caution, arguing that more evidence is needed before approving or widespread use of LepriCon vaccines. They emphasize the need for long‑term observation and transparent communication about risks, and criticize the potential for insufficient understanding among healthcare workers and the public. They also urge that any future vaccine development should consider the possibility of genome editing, recombination, and exosome‑mediated spread, and stress the importance of not underestimating possible adverse effects. - Real‑world observations and skepticism about hype: Several speakers underscore that the danger is not merely hypothetical; there are reports of adverse events, including stroke‑like conditions, inflammatory diseases, and immune dysregulation in vaccinated individuals. They stress that the evolution and mutation of replicating vaccines could outpace current surveillance methods, and that “information manipulation” or lack of transparent reporting could mislead the public about risks. - Final reflections and call to action: The concluding messages advocate recognizing the potential failures of messenger RNA vaccines and acknowledging that both conventional and replicating platforms may carry risks. The speakers urge ongoing critical analysis, cautious progression, and robust verification of claims through transparent, independent investigation. They close with thanks to the organizers and a hope that the discussion may contribute to broader public awareness and informed decision‑making. Notable emphasis and unique considerations - The core concern centers on LepriCon vaccines’ replication, mutation, and potential to spread beyond the vaccinated person; exosome transport and genomic/cellular integration are highlighted as mechanisms that could generate new risks not present with non‑replicating vaccines. - The discussion stresses that IGG4 responses could become alarmingly high after certain doses, potentially leading to immunosuppressive effects or autoimmune phenomena, and presents IGG4‑related disease as a potential complication to monitor. - The speakers insist that safety and transparency are paramount, and that misinformation or optimistic narratives about rapid vaccine development could lead to harm if new platforms are adopted without comprehensive evaluation. Overall, the symposium foregrounds cautious scrutiny of replicating vaccine platforms, frames potential biological and regulatory risks, and calls for careful, evidence‑based assessment before broader deployment.

Speaker 0 asks: "Do you think there's evidence that the changes to people to their genetic structure wrought by these vaccines could be passed on to their children?" Speaker 1 responds: "The McCullough Foundation, of which I am the vice president, we just published a person who had cancer of the bladder, which is a very severe cancer, in that tumor, so in the bladder cells that had become dysplastic, that messenger RNA was found in the cancerous cells of this tumor. So it seems to be integrating. Now the question is, is it integrating in a way that is can be passed on to the offspring, or is it so dysfunctional that it's killing the host before it can be passed on? And and I don't know that we yet know that, but remember, the science is the topography of ignorance. I mean, there's a lot about this that is is very, very concerning. There's also a study that this messenger RNA seems to have transcribed into liver cells."

The speaker raises concerns about the mRNA vaccines, pointing out discrepancies between official narratives and what they claim to have observed under a microscope. They mention the presence of RNA fragments and self-assembling nanotechnology in the vaccines. The toxicity of the COVID vaccines is discussed, with a mention of excess mortality and adverse effects on fertility. The speaker suggests that the vaccines are part of a depopulation plan and could be considered biological weapons. They claim to have found evidence of these vaccines in human blood. The lack of mainstream media coverage is also mentioned.

The symposium revolves around the science and safety implications of Replicating/Replicon vaccines and broader RNA vaccine platforms, with a sequence of expert presentations and reactions from the panel. -荒川博 presents the central premise that Replicon vaccines (replicating or self-amplifying RNA vaccines) raise unique safety and biosafety concerns beyond traditional mRNA vaccines. He frames the discussion around the idea that these vaccines “increase and mutate” within the host, potentially evolving in ways that could affect humans and populations. He references specific real-world events and case observations, including severe vascular events and tissue damage in some vaccine recipients, as motivation to scrutinize this technology carefully. -荒川 emphasizes that Replicon vaccines differ from conventional mRNA vaccines by embedding replicative machinery so that the RNA self-amplifies inside cells. He explains that, unlike ordinary mRNA vaccines, replication can produce more copies of the RNA and additional viral proteins, potentially leading to unexpected immune and biological consequences. He notes that the Alpha virus replicase used in some designs is designed to enable replication and increased antigen production, but that high mutation and recombination potential could yield variants or new properties. -藤本、藤田（参加者は複数） and others discuss the science of replication in viruses, highlighting the Central Dogma nuances. They describe that normally DNA → RNA → protein is the standard flow, but some viruses (RNA viruses and certain retroviruses) can reverse or bypass parts of this flow (RNA to DNA in retroviruses; RNA to RNA replication in some RNA viruses). This provides a conceptual basis for why replicating vaccines could, in principle, generate abnormal replication dynamics or new variants. -コロナウイルスRNAワクチンの議論では、Repliconの増殖と変異率の高さ、組換えの可能性、体内拡散の可能性を挙げて、「増えると変わる」性質が人の体内でどう影響するかが核心テーマとして挙げられます。アルファウイルス由来のレプリカーゼを使う場合、修復機能が不完全なRNAの増殖過程で、予想外の抗原変異を引き起こすリスクがあるとの指摘が出てきます。 -リスクの具体例として、ウイルスの殻（エンベロープ）とエクソソームを介した分布、自己拡散型ワクチンによる体内の遺伝子素材の取り込み、さらには他の人へ感染・伝播するアウトブレークの可能性、という仮説的懸念が提示されます。レプリコンワクチンは「空の遺伝子を抗原遺伝子に置き換えた陰性空間を持つウイルス」という説明が繰り返され、組換え・遺伝子交換・逆転など、従来のDNA・RNA動態の外に出る事象が起こり得ると議論されます。 -一部のスピーカーは、日本での試験・臨床・規制の動きを取り上げ、FDA/国内基準値を超えるDNA混入、SV40プロモーター混入の報告など、製品レベルでの懸念を指摘します。ケビン・マッカーシー氏の分析紹介では、日本市場で使われているファイザー社のコロナワクチンにDNA混入の痕跡があったこと、SV40プロモーター混入の可能性が指摘され、脂質ナノ粒子を通じた細胞内へのDNA／エクソンの取り込みリスクが懸念事項として挙げられます。これにより、RNAワクチンのフォーマットが終わるのではなく、プラットフォーム自体が拡大・進化する過程で新たなリスクを生む可能性を示唆します。 -IGG4関連疾患の急増とコロナワクチンの関連を例示する報告を紹介。IGG-4抗体が高値となり、多様な臓器炎症を引き起こす病態が観察され、ウイルス感染・ワクチン接種と免疫抑制・過剰免疫の連携が臨床で見られるケースの存在が議論されました。これにより、免疫の過剰反応・異常免疫を招く可能性があるとの懸念が示唆されました。 -ウイルス学・免疫学の専門家は、Repliconワクチンの「増殖・変異・組換えの三拍子」が、長期的・広範な公衆衛生影響をもたらし得る点を強調します。従来のウイルスワクチンの枠組みを超え、自己拡散・他者伝播・遺伝子汚染の可能性を定量的に評価する必要があると主張します。 -議論は、Repliconの潜在的リスクと実利を天秤にかけるもので、現時点で「安全」と断定できないという結論に至る場面が多くありました。実臨床での結果を長期観察で検証し、エビデンスに基づく判断を求める声が複数の speaker から出ました。 -最後に、メディア・一般市民への啓蒙の喚起と、透明性の高い情報提供、そして次世代ワクチン開発の安全性を担保するための厳格な規制・評価の重要性が強調されました。現状の科学的理解には限界があり、今後も公衆衛生への影響を見据えた厳密な検証が不可欠であるとの結論が共有されました。 overall, the event centers on the scientific basis, potential risks, and regulatory considerations of Replicon vaccines, contrasted with traditional mRNA vaccines, with emphasis on mutation, recombination, potential horizontal spread, DNA contamination concerns, immune dysregulation (including IGG4-associated phenomena), and the need for rigorous, transparent evaluation before broad deployment.

The speaker describes unbridled enthusiasm and irrational exuberance for life as sacrificing safety. They state they presented autopsy work on death after COVID-19 vaccination at the American Society of Microbiology, where thousands of microbiologists, vaccinologists, and immunologists attended. As people visited, the speaker was stunned by what they call scientific seduction by messenger RNA technology. They predict a cataclysmic recognition that mRNA platforms are unsafe, claiming there is no way to break down pseudourrogenated messenger RNA. The speaker asserts that circulating messenger RNA from Pfizer or Moderna remains in patients’ bloodstream three years after the shots, described as intact.

Two speakers are at the Japanese parliament for the International Crisis Summit 6 to stop the "disaster of mRNA vaccine technology called the Replicon vaccine," a self-amplifying mRNA vaccine. One speaker states that since the release of the "last genetic experiment," Japan has averaged 25% excess mortality. He claims everyone knows someone who has died, has cancer, or is sick. He says they are ready to release a potentially more radical genetic experiment, calling it a safe and effective vaccine, even without long-term studies on mice. The other speaker says there is a danger of it spreading into the environment and among the general population, possibly through shedding, harming people without their knowledge or consent. They urge people to support the International Crisis Summit 6 and to not take the shots.

The mRNA in vaccines can replicate, including the replication engine, leading to potential spread from person to person. Concerns exist about the inability to stop this replication, with unknown consequences for humanity. The spike protein in these vaccines can be toxic, affecting various tissues. Deployment of this technology in vaccines for humans is already happening, with over 4,000 people injected in Japan.

Self-amplifying RNA (saRNA) is being fast-tracked in the US after approval in Japan and Europe. SaRNA is similar to mRNA but replicates itself like a virus. Concerns are raised about its biodistribution and persistence, suggesting it could act as an STD. A white paper calls for a halt on saRNA vaccine deployment until comprehensive safety studies address contagious risks. It is argued that Moderna and Pfizer shots already shed and act as STDs, transmitting spike protein infections. SaRNA is designed to replicate and remain strong, potentially causing a contagious cancer-like disease. COVID shots may contain cancer-causing viruses like SV40, possibly with SV40 promoters to enhance their effectiveness. mRNA degrades over time, but saRNA is designed to make more of itself. There are ways to detox from mRNA, but not a self-replicator. Ultramethylene Blue is promoted for cell health, available at the Alex Jones store.

Dr. Chris Shoemaker warns of a new self-replicating RNA technology potentially approved in Japan, which could spread like a virus and cause mass, involuntary vaccination. This RNA could turn people into factories, producing spike proteins and vaccinating those nearby through exosomes. He claims mortality rates are already five times higher due to spike protein-generating mRNA injections, citing a Cleveland Clinic study showing increased COVID-19 illness in vaccinated staff. He alleges hospitals are quietly dropping vaccine mandates due to legal liability. Dr. Shoemaker states this new technology is more dangerous than the original virus and could lead to an explosion of early-onset cancers because Pfizer lied about the presence of an SV40 genomic component in their mRNA product, which promotes cancer. He urges the public to resist this technology, as existing treatments may be less effective against it. He believes this could be worldwide by March 2025.

The speaker expresses concern about the mRNA vaccines, specifically the Pfizer and Moderna ones, stating that they believe there are deliberate toxicities built into these vaccines. They explain that normally the immune system only attacks foreign substances, but when mRNA is introduced to the body, it instructs cells to produce a foreign protein, causing the immune system to attack the cells. The speaker believes this mechanism of toxicity is intentional and points out that all four companies producing COVID-19 vaccines chose the same spike protein, which they claim is biologically active and potentially harmful. They find it unlikely that multiple companies would independently choose the same solution.

The livestream discussed nanotechnology found in COVID-19 jabs, creating its own neural networks and AI within the body. This technology, developed by DARPA, poses a serious threat as it can replicate and control itself internally. The speaker urges viewers to spread awareness and take action to prevent the exponential growth of this AI within the human body. The situation is dire, and urgent measures are needed to address this issue before it escalates further.

The speaker discusses the potential contamination of RNA vaccines and the lack of control and regulation surrounding their authorization. They mention that purification methods may fail, resulting in the presence of remaining books of life in the vaccines. The speaker expresses concern over the automatic authorization of future RNA vaccines without considering efficacy, safety, or contamination. They highlight that the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) have declared their intention to implement RNA vaccination in all areas of human and veterinary medicine. The conversation ends with a comment about the situation being concerning.

The speakers discuss the potential effects of COVID-19 mRNA vaccines. Speaker 1 explains that the idea of DNA fragments and reverse transcription in vaccines is a distinct possibility proven in vitro (in the laboratory) but not as solidly established in real-life humans. He says the machinery exists to reverse transcribe the synthetic mRNA in “these gene products” but notes skepticism about certain public figures and officials who allegedly ignored earlier communications. He cites Denis Rancourt’s data, claiming the vaccine has killed 17 million people and that the injury-to-kill ratio is 34.4. He translates this to global totals of 602 million injured or killed, with approximately 700,000 Americans killed and 2.5 million injured in the United States, describing this as an unprecedented injury-to-kill ratio in medicine and military contexts. He asserts that deadly gene products should have been removed from the market and from Florida two years ago. Speaker 0 asks whether Latipo was alerted two years ago and whether he ignored the warnings. Speaker 1 confirms that Latipo, Ashley Moody, and DeSantis did not respond to communications over the past two years, but notes that Latipo is now taking some action. The conversation shifts to how people can respond health-wise. Speaker 1 contends that health care systems and governments are corrupt, claiming the government has spent trillions of dollars to capture healthcare systems and push dangerous narratives. He urges listeners to leave the conventional healthcare system, describing it as corrupt and implying that healthcare professionals are silenced or fired for speaking out. He promotes an alternative health approach through a parallel system and mentions an emergency medical kit intended to address multiple dangerous diseases and scenarios, asserting that timely access to certain drugs is limited through ordinary medical channels. Throughout, Speaker 1 emphasizes drastic distrust of mainstream medical and governmental institutions, urging viewers to seek alternative health solutions and to prepare for potential health crises. He repeats that the traditional healthcare system is compromised and advocates a shift toward a different healthcare approach and emergency preparedness, including access to medications outside standard channels.

The transcript discusses self-amplifying replicon mRNA injections and asserts that they are being deployed for both humans and animals globally. It states that the UK approved Arcturus Therapeutics’ self-amplifying COVID-19 vaccine for adults over 18, and that the European Union previously approved the same inoculation for adults, placing it in both the EU and the UK. It also claims that Japan approved it in 2023, and that India has approved these replicon injections as well, indicating a global rollout. It highlights that in the United States, the USDA approved the self-amplifying mRNA particle injections for pets, specifically mentioning Merck’s Novavax NXT for dogs and cats, and asserts that this is being injected into pets and that shedding onto human owners across the US is possible. It notes that the FDA has fast-tracked an H5N1 bird flu replicon injection trial, emphasizing concern about these developments. The speaker outlines purported dangers of these replicating genetic materials, including the possibility of shedding from humans to humans or from pets to humans, and the potential for recombination with wild viruses to create chimeric mutants. It emphasizes the claimed approval of Arcturus Therapeutics’ injection “everywhere in the clinical trials” and then provides adverse event statistics: eighty-five percent suffered systemic adverse events, and fifteen percent required medical attention. A Uganda study is cited, claiming that the replicon injections induced severe blood abnormalities in ninety-three percent of recipients, with thrombocytopenia, lymphopenia, and neutropenia reported, implying degraded immune systems and increased risks of internal bleeding in a majority of participants. The Uganda study is also described as showing eighty-five percent experiencing vomiting, high fevers, and feeling absolutely terrible. The speaker concludes with a strong stance against these injections, calling them a “self amplifying assault on humanity” and arguing that they should be pulled off the market and banned for human use. The overall message is a warning about global deployment, potential shedding and recombination risks, significant adverse event rates, and a call to ban self-amplifying mRNA injections for humans. The named entities include Arcturus Therapeutics, Merck, Novavax NXT, and references to regulatory actions in the UK, EU, Japan, India, and the US.

The speaker argues that an irrational, unbridled enthusiasm for new possibilities leads to a sacrifice of safety. This enthusiasm, in their view, has adversely affected precautionary considerations and risk assessment. They reference presenting autopsy findings related to deaths following COVID-19 vaccination at the American Society of Microbiology, an event attended by thousands of microbiologists, vaccinologists, and immunologists. In conversations with attendees, the speaker was surprised by what they describe as a scientific seduction surrounding messenger RNA technology. The core concern expressed is that this eagerness to embrace mRNA platforms is accompanied by a neglect of safety considerations. The speaker asserts that there will be a cataclysmic recognition that messenger RNA technology represents an unsafe platform. They emphasize that, as they understand it, there is no way to break down certain aspects of the technology they refer to as “pseudourogenated messenger RNA,” noting this within the context of their work in research laboratories. The statement implies a belief that the degradation or metabolic processing of this form of RNA poses unresolved issues. A central, striking claim presented is that circulating messenger RNA from Pfizer or Moderna has been found in their patients’ bloodstream three years after vaccination, and that this RNA is intact. The speaker underscores this as evidence tied to their observations and research experiences, asserting the persistence of the RNA in the circulatory system over an extended period. Overall, the message conveys a perspective that rapid adoption and optimism around mRNA vaccines and technologies have overshadowed safety considerations, and it anticipates a future realization of safety concerns associated with these platforms. The speaker ties their warnings to concrete experiences at a major scientific conference and to specific, long-term biomarkers observed in patients, presenting a narrative of ongoing research findings and anticipated paradigm shifts in how the safety of mRNA vaccines is perceived.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

The speaker believes mRNA shots are a "festering wound" impacting everyone that cannot be ignored. The speaker urges the new administration to address the issue, citing 500 mRNA shots in the pipeline, 33 of which are self-amplifying. Self-amplifying means they are designed to replicate indefinitely, which the speaker finds "terrifying" because current mRNA shots already lack an "off switch." The speaker claims these self-amplifying shots are already in use in Japan, India, and the EU. The speaker believes the one in the US pipeline is for H1N1, so it may not be used unless there is an issue, but they are still experimenting with it.

The speaker believes vaccines are causing cancer, with the risk increasing exponentially with each booster, because boosters suppress T cell response, which controls cancer. Experts claim messenger RNA is safe because we are exposed to it daily and it's easily disposed of, but the speaker argues that mRNA vaccines are stabilized to prevent disposal, which is the core problem. The speaker claims that mRNA can integrate and hack your genetic code, promoting oncogenes and down-regulating suppressor genes. They state that the UK and Australia have invested heavily in mRNA technology without proper oversight. The speaker advocates for ending this culture and improving population health.

The speaker expresses concern about the mRNA vaccines, specifically the Pfizer and Moderna ones, stating that they believe there are deliberate toxicities built into these materials. They explain how the immune system normally distinguishes between self and foreign substances, but when mRNA is used to make a piece of a foreign protein, the immune system goes into attack mode. The speaker argues that these vaccines cannot be safe for mass market use as they may cause the immune system to attack its own cells. They also claim that all four companies developing COVID-19 vaccines intentionally chose the spike protein, which they believe is biologically active and potentially toxic.

We are facing a significant threat from those who have the means to contaminate the entire human genome. The mRNA vaccines could potentially affect future generations, as the injected genetic material may remain dormant until the next generation tries to have children. With billions of people already vaccinated, including millions of women capable of giving birth, there is a concern that these vaccines could introduce never-before-seen mutations into the human species. The true impact will only be known when problems arise in the offspring and subsequent generations. This is the enormity of the problem we are confronting.

Speaker asserts that extremely dangerous self-amplifying replicon mRNA injections are currently being deployed for humans and animals worldwide. A few days ago, the UK approved Arcturus Therapeutics’ self-amplifying COVID-19 injection for adults over 18, and previously the European Union approved the same replicon injection for adults, so it is in the EU and the UK. Japan approved it in 2023, and India has approved these replicon injections as well, indicating rollout across the globe. In the United States, it is claimed that the USDA approved the self-amplifying mRNA particle injections for dogs and cats, specifically Novavax NXT by Merck, suggesting active injection into pets and potential shedding onto human owners in the US. The speaker states that the FDA fast-tracked an H5N1 bird flu replicon injection trial, raising concern given the alleged dangers of these products. The speaker emphasizes the potential for shedding of replicating genetic material from humans or from pets to humans, and the possibility that these replicating constructs could recombine with wild viruses to create chimeric mutants. They highlight a high rate of adverse events associated with the Arcturus Therapeutics injection, claiming that eighty-five percent suffered systemic adverse events and fifteen percent required medical attention. A recent study in Uganda is cited, alleged to have induced severe blood abnormalities in ninety-three percent of recipients, including thrombocytopenia, lymphopenia, and neutropenia, with immune systems degraded and increased risks of internal bleeding in a majority of participants. The report also claims that eighty-five percent experienced vomiting and high fevers, and felt absolutely terrible. The speaker concludes that this self-amplifying assault on humanity needs to end, calling for these injections to be pulled from the market and banned for human use.